Wealth Enhancement Advisory Services’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.2M Buy
74,825
+6,106
+9% +$535K 0.01% 1275
2026
Q1
$2.7M Buy
68,719
+35,992
+110% +$3.3M 0.01% 1232
2025
Q4
$3.22M Sell
32,727
-15,033
-31% -$1.43M ﹤0.01% 1246
2025
Q3
$4.73M Buy
47,760
+492
+1% +$48.8K 0.01% 981
2025
Q2
$4.43M Buy
47,268
+30,007
+174% +$2.9M 0.01% 955
2025
Q1
$1.95M Sell
17,261
-1,092
-6% -$117K ﹤0.01% 1255
2024
Q4
$1.94M Buy
18,353
+3,681
+25% +$395K ﹤0.01% 1207
2024
Q3
$1.58M Buy
14,672
+1,835
+14% +$200K ﹤0.01% 1170
2024
Q2
$1.39M Sell
12,837
-2,509
-16% -$296K ﹤0.01% 1140
2024
Q1
$2.03M Buy
15,346
+2,820
+23% +$352K 0.01% 940
2023
Q4
$1.52M Sell
12,526
-487
-4% -$54.3K ﹤0.01% 995
2023
Q3
$1.46M Buy
+13,013
New +$1.65M ﹤0.01% 967

Other funds holding ZBH

Wealth Enhancement Advisory Services's ZBH Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Zimmer Biomet (ZBH) stake by 8.9% in Q2 2026, buying an estimated $535K and bringing the position to 74,825 shares worth $3.2M. The position accounts for 0.01% of the portfolio, ranked #1275.

Wealth Enhancement Advisory Services first reported a position in ZBH in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.73M in Q3 2025. 150 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Wealth Enhancement Advisory Services held 74,825 shares of Zimmer Biomet worth $3.2M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 6,106 Zimmer Biomet shares in Q2 2026, an estimated $535K.
  • Zimmer Biomet made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #1275 holding.
  • Wealth Enhancement Advisory Services first reported a position in Zimmer Biomet in Q3 2023 and has held it in 12 quarters since.
  • Wealth Enhancement Advisory Services's Zimmer Biomet position peaked at $4.73M in Q3 2025.
  • 150 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.